Product Information
HYDROCHLOROTHIAZIDE 12.5 MG CP is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.0284 per EA under NDC 50228014610. Its NADAC has been published 369 times since Jun 5, 2019.
Strength
12.5 mg/1
Manufacturer
ScieGen Pharmaceuticals Inc.NDC
50228014610
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203561On Market Since
1/14/2019
Pharmacological Classes
Price Statistics
The NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has been published 369 times since Jun 5, 2019, and over the history we have for it it has declined 21.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0284 per EA |
|---|---|
| All-time high | $0.0388 (Mar 10, 2021) |
| All-time low | $0.0263 (Jul 17, 2024) |
| 52-week high | $0.0306 |
| 52-week low | $0.0284 |
| Median price | $0.0324 |
| Average price | $0.0330 |
| Largest weekly change | +21.9% (Aug 21, 2024) |
| Weeks tracked | 369 |
| Tracking since | Jun 5, 2019 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROCHLOROTHIAZIDE 12.5 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCHLOROTHIAZIDE 12.5 MG CP, manufactured by ScieGen Pharmaceuticals Inc., is $0.0284 per EA (NDC 50228014610), effective Jun 24, 2026.
How has the price of HYDROCHLOROTHIAZIDE 12.5 MG CP changed over time?
Over the history we have for it, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has declined 21.1%. It has been tracked across 369 weekly CMS publications since Jun 5, 2019.
What are the highest and lowest recorded NADAC prices for HYDROCHLOROTHIAZIDE 12.5 MG CP?
Since Jun 5, 2019, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has ranged from a low of $0.0263 (Jul 17, 2024) to a high of $0.0388 (Mar 10, 2021), with a median of $0.0324 per EA.
Are there cheaper alternatives to HYDROCHLOROTHIAZIDE 12.5 MG CP?
10 NADAC-published products share the same active ingredient, strength, and dosage form as HYDROCHLOROTHIAZIDE 12.5 MG CP, but none are currently priced below it.
Who manufactures HYDROCHLOROTHIAZIDE 12.5 MG CP?
HYDROCHLOROTHIAZIDE 12.5 MG CP (NDC 50228014610) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification